US Food and Drug Administration (FDA) grants Breakthrough Device status to Guerbet innovation: DUOncoTM Pancreas for early detection of pancreatic lesions

US Food and Drug Administration (FDA) grants Breakthrough Device status to Guerbet innovation: DUOncoTM Pancreas for early detection of pancreatic lesions

Read the press release
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

Read the press release
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a financing from Bpifrance for Liflow®

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a financing from Bpifrance for Liflow®

Read the press release

Guerbet: Home of innovations! 

Aulnay Fill And Finish Site Copyright Patrick Allard REA (1)

Nearly a century of passion and dedication

Guerbet has become one of the leading experts in medical imaging worldwide. Collectively, we offer a full range of medical solutions and services in diagnostic imaging and interventional imaging.

Learn more about Guerbet

Discover the latest news of Guerbet

Latest news

See more
Post Linkedin Et X Picture

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

Read the press release
Hero Slider 3 Article On AI François Nicolas Redirect To Insights Section

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging

Read the press release

Let’s get connected